EUVIMEDEUVIMED entdecken
Crossref

Unravelling metabolites conferring intestinal protection in asymptomatic first-degree relatives of patients with celiac disease

Deepti Upadhyay, Prasenjit Das, Siddhartha Dattagupta, Govind K Makharia, Naranamangalam R Jagannathan, Uma Sharma

Journal of Pharmaceutical and Biomedical Analysis · 2026

DOI: 10.1016/j.jpba.2026.117685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Deepti Upadhyay und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Magnetic Resonance, All India Institute of Medical Sciences, New Delhi 110 029, India. Hauptthemen laut MEDLINE: Celiac Disease, Intestinal Mucosa, Metabolome. Die Arbeit nennt 50 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Celiac disease (CeD) is an autoimmune enteropathy; nearly 60-80% of first-degree relatives (FDRs) of CeD patients carry HLA-DQ2/DQ8 haplotypes; however, only 7.5% of them develop enteropathy. This suggests the modulation of biochemical and molecular mechanisms that might help in maintaining intestinal integrity. Thus, the present study investigated the metabolome of FDRs to gain insight into biochemical mechanisms that might help in maintaining intestinal integrity. The metabolome of small intestinal mucosal biopsies, blood plasma and urine of serologically negative first-degree relatives (FDRs, n = 50) was investigated using proton NMR spectroscopy and compared with CeD patients (n = 64) and controls (disease controls, n = 35 or healthy controls, n = 32) using both univariate and multivariate statistical analyses. The metabolic profiles of FDRs of CeD patients differed significantly from both CeD patients and controls. Higher myo-inositol and fumarate in the mucosa of FDRs suggest the role of these metabolites in modulating the immune response and inflammation, which may protect intestinal integrity in FDRs. Elevated formate and tyrosine levels in the intestinal mucosa of FDRs, compared to both CeD patients and controls, suggested alterations in gut microbiota that may support intestinal homeostasis. Furthermore, significant changes in levels of branched-chain amino acids in FDRs compared to CeD patients indicated their increased utilization for enterocytes renewal, upregulation of tight junction proteins and modulating immune response to maintain villous architecture. Our data showed that FDRs exhibit a specific metabolic signature that may represent an adaptive response aimed at maintaining intestinal homeostasis and mucosal integrity despite genetic predisposition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseIntestinal MucosaMetabolomeHumansFemaleMaleAdultFamilyHLA-DQ AntigensIntestine, SmallMiddle AgedYoung AdultAdolescentCase-Control StudiesGastrointestinal MicrobiomeChildGenetic Predisposition to Disease

Stichwörter der Autor:innen

Anti-inflammatory and Gut MicrofloraCeliac DiseaseFirst-degree relativesIntestinal MucosaNMR Metabolomics

Substanzen

HLA-DQ AntigensHLA-DQ2 antigenHLA-DQ8 antigen

Autor:innen und Institutionen

  • Department of Nuclear Magnetic Resonance, All India Institute of Medical Sciences, New Delhi 110 029, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi 110 029, India.
  • Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi 110 029, India.
  • Department of Nuclear Magnetic Resonance, All India Institute of Medical Sciences, New Delhi 110 029, India; Dept. of Radiology, Chettinad Academy of Research & Education, Kelambakkam, Tamil Nadu 603 103, India.
  • Department of Nuclear Magnetic Resonance, All India Institute of Medical Sciences, New Delhi 110 029, India. Electronic address: umasharma69@aiims.edu.

Förderung

  • India Ministry of Science & Technology Department of Biotechnology

Zitieren

APA

Upadhyay, D., Das, P., Dattagupta, S., Makharia, G. K., Jagannathan, N. R., & Sharma, U. (2026). Unravelling metabolites conferring intestinal protection in asymptomatic first-degree relatives of patients with celiac disease. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2026.117685

Vancouver

Upadhyay D, Das P, Dattagupta S, Makharia GK, Jagannathan NR, Sharma U. Unravelling metabolites conferring intestinal protection in asymptomatic first-degree relatives of patients with celiac disease. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2026.117685

BibTeX
@article{Upadhyay2026,
  author = {Upadhyay, Deepti and Das, Prasenjit and Dattagupta, Siddhartha and Makharia, Govind K and Jagannathan, Naranamangalam R and Sharma, Uma},
  title = {Unravelling metabolites conferring intestinal protection in asymptomatic first-degree relatives of patients with celiac disease},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  doi = {10.1016/j.jpba.2026.117685}
}
Kostenlos starten →